Runnymede Capital Advisors’s ResMed RMD Stock Holding History

Runnymede Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,837	Closed	-$1.17M	–	113
2025 Q4	$1.17M	Buy	+4,837	New	+$1.24M	0.67%	46

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Runnymede Capital Advisors's RMD Position: Q1 2026 in Review

Runnymede Capital Advisors sold out of ResMed (RMD) in Q1 2026, closing a stake of 4,837 shares — an estimated $1.17M sold.

Runnymede Capital Advisors first reported a position in RMD in Q4 2025 and held it in 1 quarter. The position peaked at $1.17M in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Runnymede Capital Advisors reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Runnymede Capital Advisors sold 4,837 ResMed shares in Q1 2026, an estimated $1.17M.
Runnymede Capital Advisors first reported a position in ResMed in Q4 2025 and held it in 1 quarter.
Runnymede Capital Advisors's ResMed position peaked at $1.17M in Q4 2025.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Runnymede Capital Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.